Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Retour à la liste des Items
Added by mollevi
Last modified by André Pèlegrin
Group name EquipeAP
Item Type Note
Note

Estupina, Pauline
Fontayne, Alexandre
Barret, Jean-Marc
Kersual, Nathalie
Dubreuil, Olivier
Le Blay, Marion
Pichard, Alexandre
Jarlier, Marta
Pugniere, Martine
Chauvin, Maeva
Chardes, Thierry
Pouget, Jean-Pierre
Deshayes, Emmanuel
Rossignol, Alexis
Abache, Toufik
de Romeuf, Christophe
Terrier, Aurelie
Verhaeghe, Lucie
Gaucher, Christine
Prost, Jean-Francois
Pelegrin, Andre
Navarro-Teulon, Isabelle
eng
2017/04/22 06:00
Oncotarget. 2017 Feb 24. doi: 10.18632/oncotarget.15715.
Date Added 2018/07/20 - 10:01:50
Date Modified 2019/11/15 - 13:08:09
Parent item The anti-tumor efficacy of 3C23K, a glyco-engineered humanized anti-MISRII antibody, in an ovarian cancer model is mainly mediated by engagement of immune effector cells


Who are we ?

Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).

U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)

More                                                                                                                 Join us

Contact us

Institut de Recherche en Cancérologie de
Montpellier (U1194) - Campus Val d'Aurelle

208 avenue des Apothicaires
34298 Montpellier cedex 5 FRANCE

 

insermUM1ICM

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés